2,4-thiazolidinedione has been researched along with Reperfusion Injury in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, Y | 1 |
| Hu, M | 1 |
| Qiu, Y | 1 |
| Zhang, L | 1 |
| Yan, Y | 1 |
| Feng, Y | 1 |
| Feng, C | 1 |
| Hou, X | 1 |
| Wang, Z | 1 |
| Zhang, D | 1 |
| Zhao, J | 1 |
1 other study available for 2,4-thiazolidinedione and Reperfusion Injury
| Article | Year |
|---|---|
Mitoglitazone ameliorates renal ischemia/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET.
Topics: Animals; Ferroptosis; HEK293 Cells; Humans; Iron-Binding Proteins; Kidney; Membrane Proteins; Mice; | 2023 |